Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-046714

SVP & Chief Scientific Officer sold 3,245 shares at $18.15 ($58,897)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doberstein Stephen K SVP & Chief Scientific Officer 2019-08-16 Sale −3,245 $18.15 $58,897 92,668 D: show line 1 in the form
Open-market sales · 3,245 sh · avg $18.15 · $58,897
Loading xslF345X03/doc4.xml…